Skip to main navigation Skip to search Skip to main content

Large-scale single-nuclei profiling identifies role for ATRNL1 in atrial fibrillation

  • Matthew C. Hill
  • , Bridget Simonson
  • , Carolina Roselli
  • , Ling Xiao
  • , Caroline N. Herndon
  • , Mark Chaffin
  • , Helene Mantineo
  • , Ondine Atwa
  • , Harshit Bhasin
  • , Yasmine Guedira
  • , Kenneth C. Bedi
  • , Kenneth B. Margulies
  • , Carla A. Klattenhoff
  • , Nathan R. Tucker
  • , Patrick T. Ellinor
  • Broad Institute
  • Massachusetts General Hospital
  • University of Pennsylvania
  • Bayer AG

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia in humans, yet the molecular basis of AF remains incompletely understood. To determine the cell type-specific transcriptional changes underlying AF, we perform single-nucleus RNA-seq (snRNA-seq) on left atrial (LA) samples from patients with AF and controls. From more than 175,000 nuclei we find that only cardiomyocytes (CMs) and macrophages (MΦs) have a significant number of differentially expressed genes in patients with AF. Attractin Like 1 (ATRNL1) was overexpressed in CMs among patients with AF and localized to the intercalated disks. Further, in both knockdown and overexpression experiments we identify a potent role for ATRNL1 in cell stress response, and in the modulation of the cardiac action potential. Finally, we detect an unexpected expression pattern for a leading AF candidate gene, KCNN3. In sum, we uncover a role for ATRNL1 which may serve as potential therapeutic target for this common arrhythmia.

Original languageEnglish
Article number10002
JournalNature Communications
Volume15
Issue number1
DOIs
StatePublished - Dec 2024

Fingerprint

Dive into the research topics of 'Large-scale single-nuclei profiling identifies role for ATRNL1 in atrial fibrillation'. Together they form a unique fingerprint.

Cite this